Neurology Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Mar/Apr 2024
Pg. 100-109
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 130
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 131
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 135
|
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 136
|
Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics
Rofiq Hanifah Mohd, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
|
Nov/Dec 2023
Pg. 512-521
|
Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet
Hazdi Siti Nursaqifah, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
|
Nov/Dec 2023
Pg. 522-527
|
Ipratropium Bromide 0.05% Nasal Spray
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 418-419
|
Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 317-318
|
Lamotrigine 1 mg/mL in SuspendIt Plus
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 323
|
Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 329
|
Chemical Stability of Epinephrine 10 mcg/mL Diluted in 0.9% Sodium Chloride and Stored in Polypropylene Syringes at 4 degrees C and 25 degrees C
Hook Roxanne, Neault Ashleigh, Scharrer Devan, Law Shirley, Walker Scott E, Ma Nathan H, Riss Vera
|
Jul/Aug 2023
Pg. 347-351
|
Migraine Headache Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 237
|
Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90%
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 145
|
Pilocarpine Hydrochloride 0.3% w/v Solution
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 149-151
|
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 51
|
Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 431
|
Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
|
May/Jun 2022
Pg. 233
|
Chloral Hydrate 70 mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2022
Pg. 235
|
Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 237
|
Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2022
Pg. 239
|
The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
|
Mar/Apr 2022
Pg. 110-115
|
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 140
|
Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 141
|
Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 143
|
Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 145
|
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 146
|
Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 147
|
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 148
|
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
|
Jan/Feb 2022
Pg. 65-71
|
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 502
|
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 504
|
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 505
|
Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 506
|
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 509
|
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 412
|
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 414
|
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 417
|
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 418
|
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Sep/Oct 2021
Pg. 427-430
|
Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 321
|
Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation
Odanaka Keita, Kojima Hiroki, Nakagawa Naoto
|
May/Jun 2021
Pg. 258-262
|
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 144
|
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 145
|
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 46
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Doxepin Hydrochloride 5% in Cetaphil Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 314
|
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 319
|
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 320
|
Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 321
|
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III, Everett Eric, Chamberlain Tyler
|
May/Jun 2020
Pg. 194-197
|
Baclofen 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 224
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
|
May/Jun 2020
Pg. 233
|
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley, Patel Jalpa
|
May/Jun 2020
Pg. 242-245
|
Low-dose Pilocarpine Spray to Treat Xerostomia
Zur Eyal
|
Mar/Apr 2020
Pg. 104-108
|
Acetazolamide 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 130
|
Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 132
|
Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 138
|
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
|
Mar/Apr 2020
Pg. 168-175
|
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 56
|
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 62
|
Venlafaxine 15 mg/mL in Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 63
|
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 486
|
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 488
|
Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 495
|
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah, Agu Remigius U
|
Nov/Dec 2019
Pg. 496-503
|
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George, Daleo Charles, Batson SL
|
Sep/Oct 2019
Pg. 358-364
|
Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 317
|
Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 318
|
Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
|
Jul/Aug 2019
Pg. 320-323
|
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 234
|
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
|
May/Jun 2019
Pg. 236
|
An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability
Reindel Kristin L, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang
|
May/Jun 2019
Pg. 258-263
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
|
Mar/Apr 2019
Pg. 94-104
|
Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
|
Mar/Apr 2019
Pg. 106-111
|
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
|
Mar/Apr 2019
Pg. 113-119
|
Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 151
|
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
|
Mar/Apr 2019
Pg. 157-162
|
Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure
Ip Kendice, Banov Daniel, Bassani Gus, Morgan Latisha
|
Mar/Apr 2019
Pg. 167-175
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
|
Jan/Feb 2019
Pg. 23-31
|
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah, Agu Remigius U
|
Jan/Feb 2019
Pg. 82-87
|
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 492
|
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
|
Nov/Dec 2018
Pg. 498-503
|
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 409
|
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 410
|
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 321
|
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 325
|
Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M
|
Jul/Aug 2018
Pg. 335-339
|
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 235
|
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O, Zdoryk Oleksandr A
|
May/Jun 2018
Pg. 240-246
|
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 146
|
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 148
|
Levodopa and Carbidopa Rectal Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 149
|
Prochlorperazine Edisylate 0.5% Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 150
|
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
|
Mar/Apr 2018
Pg. 172-175
|
Ranitidine 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 56
|
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 58
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George, Powers Dan, Yeung Stanley, Chen Frank
|
Jan/Feb 2018
Pg. 76-85
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
|
Jan/Feb 2018
Pg. 86-94
|
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 409
|
Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 411
|
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
|
Sep/Oct 2017
Pg. 436-439
|
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
|
Jul/Aug 2017
Pg. 282-289
|
Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 318
|
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
|
May/Jun 2017
Pg. 234
|
Meloxicam 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2017
Pg. 235
|
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
|
Mar/Apr 2017
Pg. 164-170
|
Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 65
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 506
|
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 509
|
Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 512
|
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
|
Nov/Dec 2016
Pg. 517-520
|
Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 406
|
Levetiracetam 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 409
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 326
|
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M, Collin Michael
|
May/Jun 2016
Pg. 197-201
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
May/Jun 2016
Pg. 231
|
Zolpidem Tartrate 5-mg and 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 235
|
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
|
May/Jun 2016
Pg. 236-238
|
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
|
Mar/Apr 2016
Pg. 107-113
|
Blue Goo Anti-Itch Gel
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 144
|
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 147
|
Aprepitant 80-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 48
|
Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 49
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 510
|
Memantine Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 511
|
Atropine Sulfate 1% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 242
|
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
|
May/Jun 2015
Pg. 244
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 246
|
Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 247
|
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles
Dewulf Joseph, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
May/Jun 2015
Pg. 268-270
|
Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 149
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 150
|
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
|
Mar/Apr 2015
Pg. 161-166
|
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
|
Mar/Apr 2015
Pg. 167-173
|
Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 67
|
Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 69
|
Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 495
|
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 496
|
Methylphenidate Hydrochloride 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 501
|
Tamsulosin Hydrochloride 0.2-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 503
|
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan, Asbill Scott, Sweitzer Sarah
|
Nov/Dec 2014
Pg. 504-511
|
Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 411
|
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 414
|
Sumatriptan Succinate 12-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 416
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 322
|
Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 330
|
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
Jul/Aug 2014
Pg. 345-347
|
Dibucaine 1% Ointment
Allen Loyd V Jr
|
May/Jun 2014
Pg. 236
|
Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2014
Pg. 239
|
Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 241
|
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
May/Jun 2014
Pg. 253-255
|
Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 142
|
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 144
|
Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 147
|
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
|
Mar/Apr 2014
Pg. 152-158
|
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
|
Jan/Feb 2014
Pg. 14-19
|
Neostigmine Bromide 15-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 64
|
Phenobarbital 60-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 66
|
Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 498
|
Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 503
|
Metyrosine 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 506
|
Phenytoin Sodium 50-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 507
|
Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 418
|
Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 422
|
Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 423
|
Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 335
|
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013
Pg. 344-346
|
Reserpine 0.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 237
|
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
|
Mar/Apr 2013
Pg. 113-123
|
Alcohol Dehydrated Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 145
|
Betahistine 16-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 146
|
Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 65
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 68
|
Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 70
|
Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 500
|
Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 505
|
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 506
|
Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 507
|
Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 508
|
Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 509
|
Stability of Propranolol Hydrochloride in SyrSpend SF
Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
|
Nov/Dec 2012
Pg. 513-515
|
Medical Therapy for Acquired Urinary Incontinence in Dogs
Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
|
Sep/Oct 2012
Pg. 369-375
|
Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 422
|
Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 424
|
Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 427
|
A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A, Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 270-274
|
Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
|
Jul/Aug 2012
Pg. 276-286
|
Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 334
|
Etomidate 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 335
|
Methyldopate Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 338
|
Stability of Gabapentin in SyrSpend SF
Sorenson Bridget, Voudrie Mark A II, Gehrig Dan
|
Jul/Aug 2012
Pg. 347-349
|
A Concise Discussion of Headache Types, Part 2: Migraine
Williams LaVonn A
|
May/Jun 2012
Pg. 182-188
|
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
|
May/Jun 2012
Pg. 196-205
|
Acetazolamide 100-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 238
|
Naloxone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 244
|
Orphenadrine Citrate 30-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 245
|
Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 246
|
Midazolam 5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 162
|
Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 163
|
A Concise Discussion of Headache Types, Part 1
Williams LaVonn A
|
Mar/Apr 2012
Pg. 125-132
|
Caffeine Citrate 20-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 156
|
Glycopyrrolate 0.2-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 159
|
Labetalol Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 160
|
Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 161
|
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method
Zhang Yang, Jiang Hongliang, Hutson Paul
|
Mar/Apr 2012
Pg. 170-173
|
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration
Zhang Yang, Scarlett Cameron, Hutson Paul
|
Jan/Feb 2012
Pg. 82-85
|
Calculations
Stockton Shelly J
|
Jan/Feb 2012
Pg. 69
|
Magnesium Sulfate 10% Injection (0.8 mEq/mL)
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 72
|
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
|
Nov/Dec 2011
Pg. 458-463
|
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
|
Sep/Oct 2011
Pg. 386-387
|
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 419
|
Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 420
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Bramwell Bethany
|
Jul/Aug 2011
Pg. 316-319
|
Glycopyrrolate 0.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 337
|
Riboflavin 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 343
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 242
|
Melatonin 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2011
Pg. 246
|
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 245
|
Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 156
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 157
|
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes
McCluskey Susan V, Lovely Jenna K
|
Mar/Apr 2011
Pg. 170-173
|
Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
|
Jan/Feb 2011
Pg. 27-31
|
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs
Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
|
Jan/Feb 2011
Pg. 74-77
|
Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel
|
Jan/Feb 2011
Pg. 81-84
|
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 512
|
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 513
|
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 514
|
Bromazepam 2.5-mg/mL Drops
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 515
|
Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 426
|
Fenoldopam Mesylate Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 340
|
Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
|
May/Jun 2010
Pg. 200-203
|
The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
|
May/Jun 2010
Pg. 193-199
|
Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 243
|
Lamotrigine 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 156
|
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
|
Jan/Feb 2010
Pg. 21-25
|
Trigger Point Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 75
|
Sleepless in America: Compounding with Melatonin
Wynn Tom, Rawlings Kate
|
Jan/Feb 2010
Pg. 10-13
|
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
|
Nov/Dec 2009
Pg. 498-505
|
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J, Asbill Scott
|
Nov/Dec 2009
Pg. 569-571
|
Topiramate 6-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 560
|
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Parish Roy C
|
Nov/Dec 2009
Pg. 572-573
|
Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 437
|
Chemical Stability of Scopolamine Hydrobromide Nasal Solution
Gupta Vishnu D
|
Sep/Oct 2009
Pg. 438-439
|
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms
Gupta Vishnu D
|
Sep/Oct 2009
Pg. 445-446
|
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 340
|
Compounding Naltrexone for the Treatment of Autism
Wynn Tom, Brunetti Sarah
|
Jul/Aug 2009
Pg. 296-299
|
Update on Managing Neuropathic Pain
McNulty Jack P, Muller George
|
May/Jun 2009
Pg. 182-190
|
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules
Allen Loyd V Jr
|
May/Jun 2009
Pg. 246
|
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules
Allen Loyd V Jr
|
May/Jun 2009
Pg. 249
|
Tolterodine 2-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 160
|
Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
|
Sep/Oct 2008
Pg. 398-401
|
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties
Donnelly Ronald F, Corman Celine
|
Nov/Dec 2008
Pg. 550-552
|
The Magic of Magnesium
Boomsma Diane
|
Jul/Aug 2008
Pg. 306-309
|
Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A, Mead Jay H
|
Jul/Aug 2008
Pg. 310-315
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Jul/Aug 2008
Pg. 368-371
|
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2008
Pg. 267
|
Chemical Stability of Naltrexone Hydrochloride Injection
Gupta Vishnu D
|
May/Jun 2008
Pg. 274-275
|
Topical Treatment of Neuropathic Pain
Vadaurri Vince
|
May/Jun 2008
Pg. 182-190
|
Acyclovir 5% Topical Ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 146
|
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 156-160
|
Carbamazepine Topical Preparations
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 150
|
Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
|
Jan/Feb 2008
Pg. 83-85
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
Equine Cushing's Disease: A Clinical Update
Bliss George
|
Sep/Oct 2007
Pg. 384-388
|
Ergonovine Maleate 0.2-mg/mL Injection, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 422
|
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report
McNulty Jack P
|
May/Jun 2007
Pg. 212-218
|
Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 245
|
Isoproterenol Compound Elixir
Allen Loyd V Jr
|
May/Jun 2007
Pg. 246
|
Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 249
|
Transdermal Gel in the Treatment of Postoperative Pain
Alexander Kayla, Wynn Tom
|
May/Jun 2007
Pg. 181-184
|
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
|
May/Jun 2007
Pg. 187-192
|
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
|
May/Jun 2007
Pg. 200
|
Levorphanol for the Treatment of Severe Chronic Pain
McNulty Jack P
|
May/Jun 2007
Pg. 202-211
|
Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
|
Mar/Apr 2007
Pg. 116-120
|
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Fields Shannon W
|
Mar/Apr 2007
Pg. 131
|
Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 160
|
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
|
Jan/Feb 2007
Pg. 26-27
|
Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 70
|
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 73
|
Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 75
|
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
|
Nov/Dec 2006
Pg. 434-435
|
Gabapentin 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 456
|
Migraine: A General Approach to Prevention and Treatment
Kennedy Bonnie M
|
Sep/Oct 2006
Pg. 344-350
|
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Williams Steve D
|
Sep/Oct 2006
Pg. 351
|
Midazolam Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 387
|
Nitrazepam 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 388
|
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
|
Sep/Oct 2006
Pg. 396-399
|
Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 299
|
Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 304
|
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free
Gupta Vishnu D
|
Jul/Aug 2006
Pg. 318-319
|
Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Yamreudeewong Weeranuj, Teixeira M Glaucia, Mayer Gabriele E
|
Jul/Aug 2006
Pg. 316-317
|
Carvedilol 1.25-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 220
|
Lamotrigine 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 223
|
Mexiletine Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 225
|
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol
McNulty Jack P
|
Mar/Apr 2006
Pg. 159-160
|
Hospice from a Compounding Pharmacist's Perspective
Jones Marty
|
Mar/Apr 2006
Pg. 89-93
|
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 66
|
Alprazolam 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 472
|
Clonazepam 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 474
|
Dolasetron 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 475
|
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Gupta Vishnu D
|
Nov/Dec 2005
Pg. 484-486
|
PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Neurander James A
|
Nov/Dec 2005
Pg. 487-488
|
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain
Mishkan Emilyn S
|
Sep/Oct 2005
Pg. 339-346
|
Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain
Allen Loyd V Jr
|
Sep/Oct 2005
Pg. 349-352
|
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration
Landry Christine, Forest Jean-Marc, Hildgen Patrice
|
Sep/Oct 2005
Pg. 396-298
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A
|
May/Jun 2005
Pg. 235-237
|
Amitriptyline Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 62
|
Gabapentin 2-mg/mL Injection, Preservative Free
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 64
|
Guaifenesin 50-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 65
|
Phenol 8% Injection
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 69
|
Return to Top |